Therapeutic strategies for spinal muscular atrophy: SMN and beyond

Therapeutic strategies for spinal muscular atrophy: SMN and beyond

Diğer sürümleri göster (1)

Spinal muscular atrophy (SMA) is a devastating neuromuscular disorder characterized by loss of motor neurons and muscle atrophy, generally presenting in childhood. SMA is caused by low levels of the survival motor neuron protein (SMN) due to inactivating mutations in the encoding gene SMN1. A second...

Detaylı Bibliyografya
Asıl Yazarlar:	Bowerman, M, Becker, C, Yáñez-Muñoz, R, Ning, K, Wood, M, Gillingwater, T, Talbot, K, UK SMA Research Consortium
Materyal Türü:	Journal article
Baskı/Yayın Bilgisi:	Company of Biologists 2017

Benzer Materyaller

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
Yazar:: Bowerman, M, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
Yazar:: Melissa Bowerman, ve diğerleri
Baskı/Yayın Bilgisi: (2017-08-01)

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
Yazar:: Winkelsas, AM, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Targeting the 5′ untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
Yazar:: Audrey M. Winkelsas, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy.
Yazar:: Wishart, T, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscape
Yazar:: Wood, M, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

SMN post-translational modifications in spinal muscular atrophy
Yazar:: Giulietta M. Riboldi, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01)

Spinal muscular atrophy in Venezuela: quantitative analysis of SMN1 and SMN2 genes
Yazar:: Yuri Yépez, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

Molecular Crosstalk Between Non-SMN-Related and SMN-Related Spinal Muscular Atrophy
Yazar:: Darija Šoltić, ve diğerleri
Baskı/Yayın Bilgisi: (2020-03-01)

The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy.
Yazar:: Sleigh, J, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Therapy Development for Spinal Muscular Atrophy in SMN Independent Targets
Yazar:: Li-Kai Tsai
Baskı/Yayın Bilgisi: (2012-01-01)

CORRIGENDUM to Molecular Crosstalk Between Non-SMN-Related and SMN-Related Spinal Muscular Atrophy
Baskı/Yayın Bilgisi: (2020-04-01)

The Need for SMN-Independent Treatments of Spinal Muscular Atrophy (SMA) to Complement SMN-Enhancing Drugs
Yazar:: Niko Hensel, ve diğerleri
Baskı/Yayın Bilgisi: (2020-02-01)

Restoring SMN Expression: An Overview of the Therapeutic Developments for the Treatment of Spinal Muscular Atrophy
Yazar:: Tejal Aslesh, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy
Yazar:: Valeria Valsecchi, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

The spinal muscular atrophy disease protein SMN is linked to the Golgi network.
Yazar:: Chen-Hung Ting, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

In Vivo Translatome Profiling in Spinal Muscular Atrophy Reveals a Role for SMN Protein in Ribosome Biology
Yazar:: Paola Bernabò, ve diğerleri
Baskı/Yayın Bilgisi: (2017-10-01)

Patient-specific responses to SMN2 splice-modifying treatments in spinal muscular atrophy fibroblasts
Yazar:: Ilaria Signoria, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Quantitative and structural features of the SMN1 and SMN2 genes in patients with spinal muscular atrophy 5q
Yazar:: A. I. Vlasenko, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

A single amino acid residue regulates PTEN-binding and stability of the spinal muscular atrophy protein SMN
Yazar:: Rademacher, S, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Spinal muscular atrophy.
Yazar:: Talbot, K, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Targeting SR proteins improves SMN expression in spinal muscular atrophy cells.
Yazar:: Claribel D Wee, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy
Yazar:: James N. Sleigh, ve diğerleri
Baskı/Yayın Bilgisi: (2011-07-01)

Molecular and Epidemiological Characterization of SMN Genes in Cuban Patients with Spinal Muscular Atrophy
Yazar:: Fabián Lombillo-Alfonso, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Molecular And Epidemiological Characterization Of SMN Genes In Cuban Patients With Spinal Muscular Atrophy
Yazar:: Fabián Lombillo, ve diğerleri
Baskı/Yayın Bilgisi: (2019-05-01)

What could be the function of the spinal muscular atrophy-causing protein SMN in macrophages?
Yazar:: Ines Tapken, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

Development and Translation of Therapies for Spinal Muscular Atrophy
Yazar:: Hannah K. Shorrock, ve diğerleri
Baskı/Yayın Bilgisi: (2016-07-01)

Review: neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy.
Yazar:: Murray, L, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
Yazar:: Winkelsas, AM
Baskı/Yayın Bilgisi: (2020)

Abnormal motor phenotype in the SMNΔ7 mouse model of spinal muscular atrophy
Yazar:: Matthew E.R. Butchbach, ve diğerleri
Baskı/Yayın Bilgisi: (2007-08-01)

A Single Amino Acid Residue Regulates PTEN-Binding and Stability of the Spinal Muscular Atrophy Protein SMN
Yazar:: Sebastian Rademacher, ve diğerleri
Baskı/Yayın Bilgisi: (2020-11-01)

The neuromuscular impact of symptomatic SMN restoration in a mouse model of spinal muscular atrophy
Yazar:: W. Arnold, ve diğerleri
Baskı/Yayın Bilgisi: (2016-03-01)

Gene therapy for spinal muscular atrophy: perspectives on the possibility of optimizing SMN1 delivery to correct all neurological and systemic perturbations
Yazar:: Sharon J. Brown, ve diğerleri
Baskı/Yayın Bilgisi: (2025-07-01)

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
Yazar:: Niba, Emma Tabe Eko, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
Yazar:: Niba, Emma Tabe Eko, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

P719: SMN1 deletion and silent carrier screening for spinal muscular atrophy
Yazar:: Poh San Lai, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Investigation of a recombinant SMN protein delivery system to treat spinal muscular atrophy
Yazar:: Anderton Ryan, ve diğerleri
Baskı/Yayın Bilgisi: (2014-03-01)

Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
Yazar:: Amparo Garcia-Lopez, ve diğerleri
Baskı/Yayın Bilgisi: (2018-05-01)

Analysis of the survival of motor neuron (SMN1) gene mutations in Spinal Muscular Atrophy through models
Yazar:: Owen, N, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Chapter 16 Spinal Muscular Atrophy
Yazar:: Talbot, K, ve diğerleri
Baskı/Yayın Bilgisi: (2003)